1ST.AX stock +22.22% Pre-Mkt ASX 13 Mar 2026: volume 2.08M signals interest

1ST.AX stock is trading at A$0.011 after a 22.22% pre-market rise on the ASX on 13 Mar 2026, driven by a volume spike of 2,075,140 shares. The move puts 1st Group Limited (1ST.AX) closer to its year high of A$0.015 and follows improved short-term momentum versus its 50-day average of A$0.00917. In this pre-market top-gainers note we link the price action to recent liquidity, fundamentals and our model outlook to help investors evaluate risk and opportunity.

Price action and volume for 1ST.AX stock

1ST.AX stock opened at A$0.011 and is showing a 22.22% one-day gain with intraday range A$0.011–A$0.011 and trade volume 2,075,140 shares, versus average volume 678,621.00. This relative volume of 3.06 suggests the move is demand-driven rather than idiosyncratic quote noise.

1ST.AX stock fundamentals and financial snapshot

1st Group Limited (1ST.AX) is listed on the ASX and operates in Healthcare information services with market cap A$15,586,889.00. Recent trailing metrics show EPS A$-0.01 and PE A$-1.10, price to sales 3.49 and a 50-day average price A$0.00917, reflecting a small-cap, loss-making profile with tight cash per share A$0.00110.

Technical view and Meyka AI grade for 1ST.AX stock

Technicals show a short-term lift: price above the 50-day average A$0.00917 and above the 200-day A$0.00796. Meyka AI rates 1ST.AX with a score out of 100: Score 65.47 | Grade B | Suggestion: HOLD. This grade factors S&P 500 and sector comparisons, financial growth, key metrics, forecasts and analyst consensus.

Valuation, price targets and 1ST.AX stock forecast

Meyka AI’s forecast model projects a one-year price A$0.00718 compared with the current price A$0.011, implying a model-based downside of -34.75%. For practical scenarios we flag a near-term reference price target of A$0.015 as an upside case (year high) and downside support at A$0.004 (year low). Forecasts are model-based projections and not guarantees.

Sector context and catalysts for 1ST.AX stock

1ST.AX stock sits in the Healthcare sector where three-month performance is -8.57% and average sector PE is 27.84. Key catalysts include adoption of MyHealth1st marketplace services, GoBookings SaaS contracts, and telehealth device integration. Positive contract announcements or higher SaaS uptake would likely push liquidity and lift valuation multiples.

Risks, liquidity and trading guidance for 1ST.AX stock

Risk drivers include continued negative EPS, low current ratio 0.83 and working capital deficits that may require capital raising. Liquidity is episodic despite today’s surge; shares outstanding are 1,416,989,952 which dilutes upside if new equity is issued. Traders should size positions conservatively and monitor company updates and sector news.

Final Thoughts

1ST.AX stock’s pre-market 22.22% jump on 13 Mar 2026 reflects a clear short-term buying interest and elevated liquidity with 2,075,140 shares traded. Fundamentals remain challenged: EPS A$-0.01, negative margins and modest cash per share A$0.00110. Meyka AI’s models project a one-year price A$0.00718 versus the current A$0.011, implying a model downside of -34.75%, though a near-term upside reference at A$0.015 remains feasible if adoption or contract news accelerates. Our Meyka grade (Score 65.47, Grade B, Suggestion: HOLD) frames the stock as speculative for investors who can tolerate capital risk and potential dilution. Monitor company updates, sector trends and volume patterns before acting. Meyka AI provides this analysis as an AI-powered market analysis platform; forecasts are model projections and not guarantees.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.